Prostate cancer screening in Europe – Authors' reply
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference6 articles.
1. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014
2. Determining the cause of death in randomized screening trial(s) for prostate cancer;De Koning;BJU Int,2003
3. Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?;Otto;Eur J Cancer,2010
4. A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality;Zappa;Eur Urol,2014
5. RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection;Carlsson;J Natl Cancer Inst,2014
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor expression of human chorionic gonadotropin beta mRNA and prognosis of prostate cancer treated by radical prostatectomy;Scandinavian Journal of Clinical and Laboratory Investigation;2019-07-11
2. Re: Re-evaluating PSA Testing Rates in the PLCO Trial;European Urology;2016-10
3. Screening for prostate cancer: time to put all the data on the table:;BMJ;2016-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3